MedPath

Homeopathic treatment of symptoms of menopause

Phase 2
Recruiting
Conditions
Menopausal syndrome
Registration Number
CTRI/2018/04/013410
Lead Sponsor
National Institute of Homoeopathy Ministry of AYUSH Govt of India
Brief Summary

Menopause is the final menstrual period, and occurs at an average age of 51 years. Menopause is defined as the permanent cessation of menstrual cycles where pathological causes of this state can be diagnosed. Demographic data show that every year 25 million women worldwide experience menopause . Hormone replacement therapy is the standard treatment for early symptoms in post-menopausal women, but increases the risks of stroke, heart diseases, vaginal bleeding, nausea, vomiting, migraine, mastalgia, and breast cancer in older women. Menopausal symptoms have been treated with homoeopathic medicines for more than one and a half centuries. In spite of promising potentials of homoeopathic treatment of menopausal syndrome, it has remained anecdotal rather than being evidence-based. In this open, observational, multicentric, pre-post comparison clinical trial, 100 patients will be given individualized homoeopathic medicines to examine treatment effect over 6 months. Prior to that, psychometric validity of the translated Bengali versions of the Greene climacteric scale (GCS), Menopause rating scale (MRS), and Utian Quality of Life (UQOL) questionnaires will be tested. Results will be published in scientific journals.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Cases suffering from menopausal syndrome; i.e. cessation of menstruation for at least 1 year 2.
  • Age: 40-55 years 3.
  • Ability to read Bengali 4.
  • Patients giving written consent to participate.
Exclusion Criteria
  • Patients who had an artificial menopause and were on HRT 2.
  • Patients having history of breast or reproductive organ cancer 3.
  • Patients with psychiatric diseases.
  • Cases suffering from uncontrolled systemic illness or life-threatening infections 5.
  • Cases already undergoing homoeopathic treatment for any chronic disease 6.
  • Self-reported immune-compromised state.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Greene climacteric scale (GCS); translated Bengali versionAt baseline and after 3 and 6 months
Secondary Outcome Measures
NameTimeMethod
Menopause rating scale (MRS); translated Bengali versionAt baseline and after 3 and 6 months
Utian quality of life (UQOL) scale; translated Bengali versionAt baseline and after 3 and 6 months

Trial Locations

Locations (3)

Mahesh Bhattacharyya Homoeopathic Medical College and Hospital, Govt. of West Bengal

🇮🇳

Haora, WEST BENGAL, India

National Institute of Homoeopathy, Govt. of India

🇮🇳

Kolkata, WEST BENGAL, India

The Calcutta Homoeopathic Medical College and Hospital, Govt. of West Bengal

🇮🇳

Kolkata, WEST BENGAL, India

Mahesh Bhattacharyya Homoeopathic Medical College and Hospital, Govt. of West Bengal
🇮🇳Haora, WEST BENGAL, India
Amila Modak
Principal investigator
9433432025
amilamodak@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.